Biomarin

Piper Jaffray Boosts Target on BioMarin to $52 After Addition of BMN-701 to Model
Street Insider
Sun, 07/15/12 - 12:02 pm
BMN-701
Biomarin
Pompe disease
GlaxoSmithKline rises on US and Europe drug submission, amid renewed talk of interest in Biomarin
Guardian, UK
Fri, 07/13/12 - 12:30 pm
GSK
Biomarin
M&A
GlaxoSmithKline dips on renewed talk of interest in US group BioMarin
Guardian, UK
Thu, 06/28/12 - 12:49 pm
GSK
Biomarin
M&A
Shire
BioMarin Higher as GSK Takeover Chatter Swirls
StreetInsider.com
Tue, 06/12/12 - 12:48 pm
GSK
Biomarin
M&A
BioMarin Prices Share Offering - Analyst Blog
NASDAQ
Sun, 06/3/12 - 12:24 pm
Biomarin
BioMarin to Raise Funds
Yahoo/Zacks
Thu, 05/31/12 - 06:15 pm
Biomarin
stock offering
22 Biopharma Stocks With Breakout Potential in 2012
Seeking Alpha
Tue, 05/22/12 - 11:25 am
Ziopharm
Zalicus
EXACT Sciences
Geron
Lexicon Pharmaceuticals
Nektar
Vical
Celgene
Celsion
ChemoCentryx
Clovis Oncology
Eli Lilly
JNJ
Pfizer
Elan
Biomarin
Biogen Idec
Auxilium
Arqule
Anthera
Acadia
Amicus Therapeutics
Vertex Pharmaceuticals
Noteworthy Insider Buys Last Week In 2 Beaten Down Biotechs, With 4 Other Buys And Sells
Seeking Alpha
Sat, 05/19/12 - 12:36 pm
Halozyme
Novavax
Prolor
Valeant Pharmaceuticals
Myrexis
OPKO Health
Vertex Pharmaceuticals
Edwards Lifesciences
Medivation
Biomarin
Mylan
6 High-Growth Biotech Stocks Analysts Rate As Buys
Seeking Alpha
Fri, 05/18/12 - 05:18 pm
Bacterin
Biomarin
Athersys
Affymax
Acorda Therapeutics
Alexion
6 Mid-Cap Biotechnology Stocks With Great Liquidity And Rated Buy Or Better
Seeking Alpha
Sun, 05/13/12 - 01:36 pm
Seattle Genetics
Biomarin
Jazz Pharmaceuticals
Illumina
Questcor Pharmaceuticals
Vivus
How Much Further Can Rare Diseases Carry BioMarin?
Seeking Alpha
Thu, 03/29/12 - 05:19 pm
Biomarin
Amicus Therapeutics
Sanofi
Vertex
BioMarin completes phase III trial enrollment for N-acetylgalactosamine 6-sulfatase for MPS IVA
Pharmabiz
Sat, 03/10/12 - 06:47 pm
Biomarin
mucopolysaccharidosis
Morquio A Syndrome
BMN-110
Biomarin Pharm Shares Downgraded by Zacks Investment Research to “Underperform” (BMRN)
Web Inquirer, UK
Sat, 02/11/12 - 12:53 pm
Biomarin
Don't Get Too Worked Up Over BioMarin Pharmaceutical's Earnings
Motley Fool
Fri, 02/3/12 - 09:55 am
earnings
Biomarin
Biotech 2012 Kickoff Party: Investor Preview
TheStreet.com
Wed, 01/4/12 - 10:22 am
Celgene
Vivus
Dendreon
Gilead
Incyte
YM BioSciences
ONYX Pharmaceuticals
Seattle Genetics
Vertex
Amarin
Biomarin
Biogen Idec
Regeneron
Merck KGaA
Human Genome Sciences
Clovis Oncology
Roche
Ariad
Immunogen
Medivation
Geron
InterMune
Indenix
Amag Pharmaceuticals
Mesoblast
Arena
MannKind
Keryx
Spectrum Pharmaceuticals
10 Biotech Stock Predictions for 2012
TheStreet.com
Tue, 12/20/11 - 11:13 am
Amgen
FDA
Oncothyreon
Merck KGaA
Vical
GSK
Seattle Genetics
M&A
Celgene
Biomarin
Amag Pharmaceuticals
Momenta
ONYX Pharmaceuticals
Cell Therapeutics
Roche
Aeterna Zentaris
Arena Pharmaceuticals
Vertex
Spectrum Pharmaceuticals
FDA clears $60M BioMarin drug-making plant expansion
Bizjournals.com
Tue, 11/29/11 - 08:32 am
FDA
Biomarin
3 Rallying Healthcare Stocks With Bullish Short Trends
Seeking Alpha
Sun, 11/27/11 - 12:07 pm
Biomarin
Questcor Pharmaceuticals
Medivation
11 Biotech Stocks With Bullish Short Trends
Seeking Alpha
Wed, 11/23/11 - 11:14 am
Biomarin
BioSpecifics Technologies
Complete Genomics
Incyte
Medivation
Insmed
Momenta
Questcor
Seattle Genetics
Sangamo BioSciences
XenoPort
The 8 Highest Potential Returns in Biotechnology
Motley Fool
Mon, 10/17/11 - 07:33 pm
Biomarin
Emergent BioSolutions
United Therapeutics
Gilead
3SBio
Targacept
Amgen
Celgene

Pages